Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma.

This study not only identified the molecular target for miR-10b-3p, but also provided evidence that circulating miR-10b-3p may be used as a biomarker for predicting sorafenib sensitivity in patients with HCC.